 | • レポートコード：MRC2-11QY11914 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は顔面神経麻痺治療のグローバル市場について調査・分析したレポートです。種類別（薬剤、理学療法）市場規模、用途別（病院、クリニック、研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別顔面神経麻痺治療の競争状況、市場シェア ・世界の顔面神経麻痺治療市場：種類別市場規模 2015年-2020年（薬剤、理学療法） ・世界の顔面神経麻痺治療市場：種類別市場規模予測 2021年-2026年（薬剤、理学療法） ・世界の顔面神経麻痺治療市場：用途別市場規模 2015年-2020年（病院、クリニック、研究センター、その他） ・世界の顔面神経麻痺治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、研究センター、その他） ・北米の顔面神経麻痺治療市場分析：米国、カナダ ・ヨーロッパの顔面神経麻痺治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの顔面神経麻痺治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の顔面神経麻痺治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの顔面神経麻痺治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Boston Scientific、Novartis、BioControl Medical、Cerebomed、Cyberonics、Astellas Pharma、Sucampo Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial weakness. Some other symptoms include loss of taste, hyperacusis, and decreased salivation and tear secretion.
The North American facial paralysis market is a growing market in the Americas region. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. The increasing cardiovascular rate is likely to enhance the growth of facial paralysis.
Market Analysis and Insights: Global Facial Paralysis Treatment Market
The global Facial Paralysis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Facial Paralysis Treatment Scope and Market Size
Facial Paralysis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Facial Paralysis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Boston Scientific
Novartis
BioControl Medical
Cerebomed
Cyberonics
Astellas Pharma
Sucampo Pharmaceuticals
…
Market segment by Type, the product can be split into
Medications
Physical Therapy
Market segment by Application, split into
Hospitals
Clinics
Research Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Facial Paralysis Treatment Revenue
1.4 Market by Type
1.4.1 Global Facial Paralysis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medications
1.4.3 Physical Therapy
1.5 Market by Application
1.5.1 Global Facial Paralysis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Facial Paralysis Treatment Market Perspective (2015-2026)
2.2 Global Facial Paralysis Treatment Growth Trends by Regions
2.2.1 Facial Paralysis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Facial Paralysis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Facial Paralysis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Facial Paralysis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Facial Paralysis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Facial Paralysis Treatment Players by Market Size
3.1.1 Global Top Facial Paralysis Treatment Players by Revenue (2015-2020)
3.1.2 Global Facial Paralysis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Facial Paralysis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Facial Paralysis Treatment Market Concentration Ratio
3.2.1 Global Facial Paralysis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Facial Paralysis Treatment Revenue in 2019
3.3 Facial Paralysis Treatment Key Players Head office and Area Served
3.4 Key Players Facial Paralysis Treatment Product Solution and Service
3.5 Date of Enter into Facial Paralysis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Facial Paralysis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Facial Paralysis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Facial Paralysis Treatment Market Size by Application (2015-2020)
5.2 Global Facial Paralysis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Facial Paralysis Treatment Market Size (2015-2020)
6.2 Facial Paralysis Treatment Key Players in North America (2019-2020)
6.3 North America Facial Paralysis Treatment Market Size by Type (2015-2020)
6.4 North America Facial Paralysis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Facial Paralysis Treatment Market Size (2015-2020)
7.2 Facial Paralysis Treatment Key Players in Europe (2019-2020)
7.3 Europe Facial Paralysis Treatment Market Size by Type (2015-2020)
7.4 Europe Facial Paralysis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Facial Paralysis Treatment Market Size (2015-2020)
8.2 Facial Paralysis Treatment Key Players in China (2019-2020)
8.3 China Facial Paralysis Treatment Market Size by Type (2015-2020)
8.4 China Facial Paralysis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Facial Paralysis Treatment Market Size (2015-2020)
9.2 Facial Paralysis Treatment Key Players in Japan (2019-2020)
9.3 Japan Facial Paralysis Treatment Market Size by Type (2015-2020)
9.4 Japan Facial Paralysis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Facial Paralysis Treatment Market Size (2015-2020)
10.2 Facial Paralysis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Facial Paralysis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Facial Paralysis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Facial Paralysis Treatment Market Size (2015-2020)
11.2 Facial Paralysis Treatment Key Players in India (2019-2020)
11.3 India Facial Paralysis Treatment Market Size by Type (2015-2020)
11.4 India Facial Paralysis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Facial Paralysis Treatment Market Size (2015-2020)
12.2 Facial Paralysis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Facial Paralysis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Facial Paralysis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Boston Scientific
13.1.1 Boston Scientific Company Details
13.1.2 Boston Scientific Business Overview
13.1.3 Boston Scientific Facial Paralysis Treatment Introduction
13.1.4 Boston Scientific Revenue in Facial Paralysis Treatment Business (2015-2020))
13.1.5 Boston Scientific Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Facial Paralysis Treatment Introduction
13.2.4 Novartis Revenue in Facial Paralysis Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 BioControl Medical
13.3.1 BioControl Medical Company Details
13.3.2 BioControl Medical Business Overview
13.3.3 BioControl Medical Facial Paralysis Treatment Introduction
13.3.4 BioControl Medical Revenue in Facial Paralysis Treatment Business (2015-2020)
13.3.5 BioControl Medical Recent Development
13.4 Cerebomed
13.4.1 Cerebomed Company Details
13.4.2 Cerebomed Business Overview
13.4.3 Cerebomed Facial Paralysis Treatment Introduction
13.4.4 Cerebomed Revenue in Facial Paralysis Treatment Business (2015-2020)
13.4.5 Cerebomed Recent Development
13.5 Cyberonics
13.5.1 Cyberonics Company Details
13.5.2 Cyberonics Business Overview
13.5.3 Cyberonics Facial Paralysis Treatment Introduction
13.5.4 Cyberonics Revenue in Facial Paralysis Treatment Business (2015-2020)
13.5.5 Cyberonics Recent Development
13.6 Astellas Pharma
13.6.1 Astellas Pharma Company Details
13.6.2 Astellas Pharma Business Overview
13.6.3 Astellas Pharma Facial Paralysis Treatment Introduction
13.6.4 Astellas Pharma Revenue in Facial Paralysis Treatment Business (2015-2020)
13.6.5 Astellas Pharma Recent Development
13.7 Sucampo Pharmaceuticals
13.7.1 Sucampo Pharmaceuticals Company Details
13.7.2 Sucampo Pharmaceuticals Business Overview
13.7.3 Sucampo Pharmaceuticals Facial Paralysis Treatment Introduction
13.7.4 Sucampo Pharmaceuticals Revenue in Facial Paralysis Treatment Business (2015-2020)
13.7.5 Sucampo Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Facial Paralysis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Facial Paralysis Treatment Revenue
Table 3. Ranking of Global Top Facial Paralysis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Facial Paralysis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medications
Table 6. Key Players of Physical Therapy
Table 7. Global Facial Paralysis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Facial Paralysis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Facial Paralysis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Facial Paralysis Treatment Market Share by Regions (2015-2020)
Table 11. Global Facial Paralysis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Facial Paralysis Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Facial Paralysis Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Facial Paralysis Treatment Players
Table 18. Global Facial Paralysis Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Facial Paralysis Treatment Market Share by Players (2015-2020)
Table 20. Global Top Facial Paralysis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Facial Paralysis Treatment as of 2019)
Table 21. Global Facial Paralysis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Facial Paralysis Treatment Product Solution and Service
Table 24. Date of Enter into Facial Paralysis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Facial Paralysis Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Facial Paralysis Treatment Market Size Share by Type (2015-2020)
Table 28. Global Facial Paralysis Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Facial Paralysis Treatment Market Size Share by Application (2015-2020)
Table 30. Global Facial Paralysis Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Facial Paralysis Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Facial Paralysis Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Facial Paralysis Treatment Market Share (2019-2020)
Table 34. North America Facial Paralysis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Facial Paralysis Treatment Market Share by Type (2015-2020)
Table 36. North America Facial Paralysis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Facial Paralysis Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Facial Paralysis Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Facial Paralysis Treatment Market Share (2019-2020)
Table 40. Europe Facial Paralysis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Facial Paralysis Treatment Market Share by Type (2015-2020)
Table 42. Europe Facial Paralysis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Facial Paralysis Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Facial Paralysis Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Facial Paralysis Treatment Market Share (2019-2020)
Table 46. China Facial Paralysis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Facial Paralysis Treatment Market Share by Type (2015-2020)
Table 48. China Facial Paralysis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Facial Paralysis Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Facial Paralysis Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Facial Paralysis Treatment Market Share (2019-2020)
Table 52. Japan Facial Paralysis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Facial Paralysis Treatment Market Share by Type (2015-2020)
Table 54. Japan Facial Paralysis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Facial Paralysis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Facial Paralysis Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Facial Paralysis Treatment Market Share (2019-2020)
Table 58. Southeast Asia Facial Paralysis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Facial Paralysis Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Facial Paralysis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Facial Paralysis Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Facial Paralysis Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Facial Paralysis Treatment Market Share (2019-2020)
Table 64. India Facial Paralysis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Facial Paralysis Treatment Market Share by Type (2015-2020)
Table 66. India Facial Paralysis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Facial Paralysis Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Facial Paralysis Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Facial Paralysis Treatment Market Share (2019-2020)
Table 70. Central & South America Facial Paralysis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Facial Paralysis Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Facial Paralysis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Facial Paralysis Treatment Market Share by Application (2015-2020)
Table 74. Boston Scientific Company Details
Table 75. Boston Scientific Business Overview
Table 76. Boston Scientific Product
Table 77. Boston Scientific Revenue in Facial Paralysis Treatment Business (2015-2020) (Million US$)
Table 78. Boston Scientific Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Facial Paralysis Treatment Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. BioControl Medical Company Details
Table 85. BioControl Medical Business Overview
Table 86. BioControl Medical Product
Table 87. BioControl Medical Revenue in Facial Paralysis Treatment Business (2015-2020) (Million US$)
Table 88. BioControl Medical Recent Development
Table 89. Cerebomed Company Details
Table 90. Cerebomed Business Overview
Table 91. Cerebomed Product
Table 92. Cerebomed Revenue in Facial Paralysis Treatment Business (2015-2020) (Million US$)
Table 93. Cerebomed Recent Development
Table 94. Cyberonics Company Details
Table 95. Cyberonics Business Overview
Table 96. Cyberonics Product
Table 97. Cyberonics Revenue in Facial Paralysis Treatment Business (2015-2020) (Million US$)
Table 98. Cyberonics Recent Development
Table 99. Astellas Pharma Company Details
Table 100. Astellas Pharma Business Overview
Table 101. Astellas Pharma Product
Table 102. Astellas Pharma Revenue in Facial Paralysis Treatment Business (2015-2020) (Million US$)
Table 103. Astellas Pharma Recent Development
Table 104. Sucampo Pharmaceuticals Company Details
Table 105. Sucampo Pharmaceuticals Business Overview
Table 106. Sucampo Pharmaceuticals Product
Table 107. Sucampo Pharmaceuticals Revenue in Facial Paralysis Treatment Business (2015-2020) (Million US$)
Table 108. Sucampo Pharmaceuticals Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Facial Paralysis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medications Features
Figure 3. Physical Therapy Features
Figure 4. Global Facial Paralysis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Research Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Facial Paralysis Treatment Report Years Considered
Figure 10. Global Facial Paralysis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Facial Paralysis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Facial Paralysis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Facial Paralysis Treatment Market Share by Players in 2019
Figure 15. Global Top Facial Paralysis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Facial Paralysis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Facial Paralysis Treatment Revenue in 2019
Figure 17. North America Facial Paralysis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Facial Paralysis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Facial Paralysis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Facial Paralysis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Facial Paralysis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Facial Paralysis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Facial Paralysis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
持続性顔面紅斑治療の世界市場（～2026年） Facial erythema is a very common reason for consulting a dermatologist. While often a manifestation of a benign condition, in some cases facial erythema may be the first sign of a more serious disorder and specific diagnostic tests are needed to rule out these diseases. Market Analysis and Insights:…- フェイシャルリンクルトリートメントの世界市場（～2026年） Facial wrinkle treatment involves procedures and medication intentional to delay, stop or retard the aging process. The rising geriatric population having age between 35-45 is the primary factor driving the growth of facial wrinkle treatment market. Market Analysis and Insights: Global Facial Wrinkl…
- フェイシャルエステティックリモデリングの世界市場（～2026年） Facial Aesthetic Remodeling is a cosmetic procedure entails a comprehensive evaluation of the nature of art, culture or beauty by altering the structure, style or form of something through the treatment of conditions including skin laxity, scars, excess fat, cellulite, wrinkles, moles, skin discolor…
- フェイシャルリジュべネーションの世界市場（～2026年） Facial rejuvenation is a combination of cosmetic procedures that are used to restore the youthful appearance to the human face. Growth in the facial rejuvenation market is mainly driven by healthy economic growth witnessed in most countries, leading to rising in disposable income levels and lifestyl…
- 3D顔認識システムの世界市場（～2026年） 3D facial recognition is known to be the device in the world to be able to visually identify a person as easily as people identify one another. 3D facial recognition is an end-to-end electronic process that ensures customer convenience and compliance with several security regulations. The increased …